Beth Israel Medical Center

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Beth Israel Medical Center sits in the top decile of US sponsors by registered trial count (#407 of 15,742 sponsors by registered trial count).

44 total trials none currently recruiting 33 completed early-phase tilt top decile by trial count

Beth Israel Medical Center: 44 sponsored US clinical trials, none currently recruiting.

Beth Israel Medical Center sponsors 44 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 33 completed. 5 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is IBS, with 1 trials.

Top-decile sponsor footprint

Beth Israel Medical Center ranks in the top decile of sponsors by registered trial count (#407 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 27/100

33 of 44 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

44 total, page 1 of 1

COMPLETED NA

Integrative Approaches to Managing Irritable Bowel Syndrome (IBS)

NCT02436603

COMPLETED NA

Group Acupuncture for Pain

NCT02328586

COMPLETED

The Impact of Fellow-performed Cardiopulmonary Ultrasound Exams

NCT02186197

COMPLETED NA

Improving Compliance With Medical Testing Guidelines

NCT02430948

TERMINATED Phase 2

Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)

NCT02019979

TERMINATED NA

Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma

NCT02039778

COMPLETED

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

NCT01933035

COMPLETED NA

Efficacy of Ultrasound to Guide Management During a Rapid Response Event

NCT01838343

COMPLETED NA

Study to Assess Stairs as an Outcome Measure in Individuals With Pulmonary Disease

NCT01835886

COMPLETED NA

A Single Blind Study of Cranial Electrical Stimulation in Bipolar II Disorder

NCT01909011

COMPLETED NA

Safety and Efficacy of Endotracheal Intubation Using Glidescope Video-Laryngoscope

NCT01683526

COMPLETED Phase 1

Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy

NCT01682499

TERMINATED Phase 1

To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors

NCT02410174

TERMINATED Phase 2

Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol

NCT01760252

COMPLETED NA

Impact of Music Therapy on Anxiety in Patients With Cancer Undergoing Simulation for Radiation Therapy

NCT02150395

COMPLETED NA

Effects of Clinical Music Improvisation on Resiliency in Adults Undergoing Infusion Therapy

NCT02261558

COMPLETED Phase 3

Peri-Operative Lidocane, Ketamine, or Lidocane and Ketamine Combination, Infusion for Patients Undergoing Spine Surgery

NCT01983020

COMPLETED Early Phase 1

Comparison Study of the Nintendo Wii Versus Playstation2 in Enhancing Laparoscopic Skills

NCT01483677

TERMINATED Phase 2

Transcranial Stimulation (tDCS) For the Treatment of Neuropathic Facial Pain

NCT01849796

COMPLETED NA

'Acupuncture Therapy' for Pain and Function Recovery in Spine Surgery Patients

NCT01304979

COMPLETED Phase 2

The Effect of Milnacipran in Patients With Fibromyalgia

NCT01108731

COMPLETED NA

Adaptive Radiation Therapy for Head & Neck Cancer Patients

NCT01853670

COMPLETED NA

Study of Mattress Type in Fibromyalgia

NCT01108718

COMPLETED NA

Effect of Creatine on Serum and Urine Creatinine

NCT01367717

COMPLETED NA

Pilot Study of Transcranial Stimulation (tDCS)to Relieve Neuropathic Pain in Cancer Patients

NCT01948050

COMPLETED NA

Effects of Music Therapy on the Recovery of Patients Undergoing Spine Surgery

NCT02145221

TERMINATED Phase 2

Neo-Adjuvant FOLFOX for Rectal Carcinoma

NCT00832299

TERMINATED Phase 1

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer

NCT00924807

COMPLETED NA

Music Therapy in the Treatment of Chronic Obstructive Pulmonary Disease

NCT02146235

TERMINATED Phase 4

Anxiety in Recovering Opiate Dependence

NCT00668265

COMPLETED

Survey of Testosterone Levels in Male Cancer Patients

NCT00483418

COMPLETED NA

Adherence to a Recommended Exercise Regimen in Colorectal Cancer Patients

NCT00977613

COMPLETED Phase 1

Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy

NCT01227642

COMPLETED Phase 2

Integrative Medicine Approach to the Management of Asthma in Adults

NCT00843544

COMPLETED NA

The Effects of Music Therapy as a Complementary Intervention in the Treatment of Pediatric Asthma

NCT02201836

TERMINATED Phase 4

Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver

NCT00274495

COMPLETED Phase 4

Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy

NCT00266318

TERMINATED Phase 4

The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study

NCT00164099

COMPLETED

Delayed Nausea and Vomiting in Patients With Colorectal Cancer Receiving Oxaliplatin

NCT00729677

COMPLETED NA

Study of Unilateral Neck Irradiation in Patients With SCC of the Head and Neck

NCT00206752

COMPLETED Phase 2

Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer

NCT00831181

COMPLETED Phase 2

Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed Mania

NCT00206778

TERMINATED Phase 2

Risperidone vs. Paroxetine for Panic Attacks

NCT00206765

COMPLETED NA

A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks

NCT00457106

Phase Distribution

PhaseTrial count
Phase 1 5
Phase 2 9
Phase 3 1
Phase 4 4

How the Beth Israel Medical Center early-phase archive is shaped

44 indexed studies, none listed as recruiting (0% open); 33 completed (75%).

Phase mix: 5 late (III/IV) vs 14 early (I/II) (early-phase heavy).

Top condition: IBS (1 trial), 6 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Beth Israel Medical Center: archived-pipeline peers nationwide

Peers matched on 44 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Beth Israel Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01020304050 0%2%4%6%8%10% Total trials Recruiting share Beth Israel Medical CenterAgios PharmaceuticalsInnovative MedicalKowa Research InstituteMedtronic Cardiovascular10xBio22nd Century Group23andMe3-C Institute for Social Development
Beth Israel Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Beth Israel Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 44 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Beth Israel Medical Center page

44 registered trials is a research-attention snapshot, not an endorsement of Beth Israel Medical Center or any single study.

  • None of Beth Israel Medical Center's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • IBS is the condition Beth Israel Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See IBS trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Beth Israel Medical Center pipeline card: 44 registered trials from official public datasets.Report a data error.